Skip to main content

Diagnostic options ยท UAE

Histology tests in Dubai & UAE

Compare available Histology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

107

Listed price range

450.00โ€“15,600.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Histology test prices

Showing 1โ€“15 of 107 matching tests.

Histology diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-1820
ALK D5F3 Immunohistochemistry Test

This diagnostic test evaluates tumor tissue for the presence and expression level of the ALK protein, a key biomarker for targeted cancer therapy.

Archival Tissue (FFPE block or formalin-fixed specimen) 5โ€“7 business days 950.00 AED
View
View test specifications and preparation
What it measures
["ALK protein expression", "ALK gene rearrangement"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis and treatment guidance for non-small cell lung cancer (NSCLC)", "Evaluation of other malignancies where ALK rearrangements are relevant"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94482-6 ICD-10: C34.9
Clinical summary
This diagnostic test evaluates tumor tissue for the presence and expression level of the ALK protein, a key biomarker for targeted cancer therapy.
TEST-36
ALK-1 Immunohistochemistry (IHC) Test

This diagnostic test evaluates the presence or absence of ALK protein expression within tumor tissue.

FFPE Tumor Block or Formalin-Fixed Tissue 10 Working Days 550.00 AED
View
View test specifications and preparation
What it measures
["ALK protein expression"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of non-small cell lung cancer (NSCLC)", "Diagnosis of anaplastic large cell lymphoma (ALCL)", "Determining eligibility for ALK-targeted therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 10521-1 ICD-10: C34.90, C85.70, Z15.01
Clinical summary
This diagnostic test evaluates the presence or absence of ALK protein expression within tumor tissue.
TEST-1837
AMACR Immunohistochemistry Test

This diagnostic test evaluates formalin-fixed paraffin-embedded tissue sections for the presence and expression level of the AMACR protein.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Slides 5-7 days 550.00 AED
View
View test specifications and preparation
What it measures
["AMACR protein expression", "Histomorphology"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of prostate adenocarcinoma", "Differentiation from benign prostatic hyperplasia", "Evaluation of suspicious prostate biopsies or resections"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50196-1 ICD-10: C61, D07.5, Z15.03
Clinical summary
This diagnostic test evaluates formalin-fixed paraffin-embedded tissue sections for the presence and expression level of the AMACR protein.
TEST-1927
ATRX Immunohistochemistry (IHC) Test

This diagnostic test evaluates the presence or absence of the ATRX protein in tumour tissue samples.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slides 5โ€“7 working days 600.00 AED
View
View test specifications and preparation
What it measures
["ATRX nuclear protein expression", "Loss of ATRX protein"]
Parameters
[]
Preparation
["Ensure original histopathology reports and clinical history accompany the sample", "Do not alter prescribed medications without consulting your oncologist"]
Indications
["Characterization of glioma", "Sarcoma profiling", "Diagnosis of IDH-mutant astrocytomas"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100667-0 ICD-10: C71.9
Clinical summary
This diagnostic test evaluates the presence or absence of the ATRX protein in tumour tissue samples.
TEST-1800
Biopsy Acetylcholinesterase (AChE Stain) Test

This diagnostic test evaluates the presence and activity of the acetylcholinesterase enzyme in a tissue biopsy sample.

Biopsy Tissue 5 business days 550.00 AED
View
View test specifications and preparation
What it measures
["Acetylcholinesterase enzyme activity", "Enzyme localization in tissue"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without consulting your doctor", "Follow specific instructions provided by your physician regarding biopsy preparation"]
Indications
["Suspected Hirschsprung disease", "Evaluation of certain neuromuscular disorders", "Prenatal genetic condition assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100373-9 ICD-10: Q43.1
Clinical summary
This diagnostic test evaluates the presence and activity of the acetylcholinesterase enzyme in a tissue biopsy sample.
TEST-1789
Biopsy Electron Microscopy Test

This diagnostic test evaluates tissue ultrastructure at the sub-nanometer level to identify abnormalities indicative of complex diseases.

Tissue biopsy (glutaraldehyde-fixed) 21 days from sample receipt 1,600.00 AED
View
View test specifications and preparation
What it measures
["Cellular organelles", "Basement membrane abnormalities", "Viral particles", "Ultrastructural tissue morphology"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without consulting your doctor.", "Follow specific instructions provided by your referring physician regarding biopsy preparation."]
Indications
["Diagnosis of genetic disorders", "Diagnosis of renal diseases", "Diagnosis of rare neoplastic diseases", "Inconclusive light microscopy results"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60578-0 ICD-10: Z03.9
Clinical summary
This diagnostic test evaluates tissue ultrastructure at the sub-nanometer level to identify abnormalities indicative of complex diseases.
TEST-1795
BRAF V600E Immunohistochemistry (IHC) Test

This diagnostic test evaluates tumor tissue for the presence of the BRAF V600E mutation protein using immunohistochemistry.

Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Block or Biopsy Slides 5 working days (FFPE block) 550.00 AED
View
View test specifications and preparation
What it measures
["BRAF V600E mutant protein"]
Parameters
[]
Preparation
["No fasting or special preparation required", "Provide histopathology report, biopsy site, and clinical history"]
Indications
["Suspected melanoma", "Suspected colorectal carcinoma", "Suspected non-small cell lung cancer", "Guidance for BRAF inhibitor therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95163-7 ICD-10: C80.1, Z85.9
Clinical summary
This diagnostic test evaluates tumor tissue for the presence of the BRAF V600E mutation protein using immunohistochemistry.
TEST-1796
Breast Biopsy (Modified Radical Mastectomy) with ER, PR, HER2/neu, Kiโ€‘67 Panel Test

This diagnostic test evaluates the expression levels of estrogen receptor (ER), progesterone receptor (PR), HER2/neu, and the proliferation marker Ki-67 in breast cancer tissue.

Archival Surgical Tissue (FFPE Block / Slides from Modified Radical Mastectomy) 6 Days (Secure Medical Courier Retrieval inclusive) 1,700.00 AED
View
View test specifications and preparation
What it measures
["Estrogen Receptor (ER) expression", "Progesterone Receptor (PR) expression", "Human Epidermal Growth Factor Receptor 2 (HER2/neu) overexpression", "Ki-67 proliferation index"]
Parameters
[{"name": "Estrogen Receptor (ER)", "reference_range": "Scored using Allred score"}, {"name": "Progesterone Receptor (PR)", "reference_range": "Scored using Allred score"}, {"name": "HER2/neu", "reference_range": "Scored using ASCO/CAP guidelines (0, 1+, 2+, 3+)"}, {"name": "Ki-67", "reference_range": "Reported as percentage index"}]
Preparation
[]
Indications
["Post-modified radical mastectomy breast cancer subtyping", "Guiding treatment decisions (hormonal, targeted, chemotherapy)", "Prognostic assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 85319-2 ICD-10: C50.9
Clinical summary
This diagnostic test evaluates the expression levels of estrogen receptor (ER), progesterone receptor (PR), HER2/neu, and the proliferation marker Ki-67 in breast cancer tissue.
TEST-17
Breast Cancer ER, PR, HER-2, Ki-67 Panel Test

This diagnostic test evaluates hormone receptor status (ER, PR), HER2 protein overexpression, and tumour cell proliferation (Ki-67) in breast cancer tissue.

Formalin-fixed paraffin-embedded (FFPE) tumour block or 10% neutral-buffered formalin tissue 10 working days 2,000.00 AED
View
View test specifications and preparation
What it measures
["Estrogen Receptor (ER) expression", "Progesterone Receptor (PR) expression", "HER2/neu protein overexpression", "Ki-67 proliferation index"]
Parameters
[{"name": "Estrogen Receptor (ER)", "reference_range": null}, {"name": "Progesterone Receptor (PR)", "reference_range": null}, {"name": "HER2/neu", "reference_range": null}, {"name": "Ki-67", "reference_range": null}]
Preparation
["No fasting required", "No medication changes required"]
Indications
["Diagnosis of breast cancer", "Prognosis assessment", "Prediction of response to targeted therapies", "Guidance for treatment planning (hormonal therapy, anti-HER2 therapy, chemotherapy)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48600-0 ICD-10: C50.9
Clinical summary
This diagnostic test evaluates hormone receptor status (ER, PR), HER2 protein overexpression, and tumour cell proliferation (Ki-67) in breast cancer tissue.
TEST-453
Breast Metastatic Marker Test

This test evaluates serum levels of CA 15-3 and performs immunohistochemical profiling (ER, PR, HER2/neu, Ki-67) on tumour tissue.

Peripheral blood (serum) for CA 15โ€‘3; Formalinโ€‘fixed paraffinโ€‘embedded (FFPE) tissue block for IHC and fragment analysis Same day for CA 15โ€‘3; 5โ€‘7 business days for tissue components 750.00 AED
View
View test specifications and preparation
What it measures
["CA 15-3 (serum)", "Estrogen Receptor (ER) (tissue)", "Progesterone Receptor (PR) (tissue)", "HER2/neu (tissue)", "Ki-67 (tissue)", "Microsatellite Instability (optional, tissue)"]
Parameters
[{"name": "CA 15-3", "reference_range": null}, {"name": "ER", "reference_range": null}, {"name": "PR", "reference_range": null}, {"name": "HER2/neu", "reference_range": null}, {"name": "Ki-67", "reference_range": null}]
Preparation
["No fasting required for blood draw", "Provide prior histopathology reports", "Provide exact biopsy site or block location for tissue retrieval"]
Indications
["Detection of metastatic breast cancer", "Monitoring disease progression or response to therapy", "Prognostic assessment in breast cancer patients"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 17877-9 ICD-10: Z85.3, R97.0, C50.919
Clinical summary
This test evaluates serum levels of CA 15-3 and performs immunohistochemical profiling (ER, PR, HER2/neu, Ki-67) on tumour tissue.
TEST-1969
C-MYC Immunohistochemistry Test

This diagnostic test evaluates the presence and level of c-MYC protein overexpression in tumor tissue samples.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Unstained Slides 5โ€“7 business days from receipt of specimen 550.00 AED
View
View test specifications and preparation
What it measures
["c-MYC protein expression levels"]
Parameters
[]
Preparation
["Submit complete histopathology report", "Submit biopsy site and clinical history"]
Indications
["Diagnosis of aggressive cancers", "Prognosis assessment", "Guidance for targeted therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48677-9 ICD-10: C85.90
Clinical summary
This diagnostic test evaluates the presence and level of c-MYC protein overexpression in tumor tissue samples.
TEST-492
CA 27.29 Breast Cancer Marker Test

This diagnostic test evaluates the level of CA 27.29, a tumor marker associated with breast cancer, in the blood.

Serum or Plasma (Venous Blood) 2โ€“3 weeks (14โ€“21 business days) 1,800.00 AED
View
View test specifications and preparation
What it measures
["MUC1 glycoprotein", "Tumor marker levels"]
Parameters
[{"name": "CA 27.29", "reference_range": null}]
Preparation
["No fasting required", "Provide a brief clinical history", "Sign the mandatory consent form", "Disclose current medications, recent biopsies, or signs of infection"]
Indications
["Monitoring breast cancer treatment response", "Detecting breast cancer recurrence", "Assessing cancer activity in metastatic settings"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 10231-0 ICD-10: Z85.3, Z08.0
Clinical summary
This diagnostic test evaluates the level of CA 27.29, a tumor marker associated with breast cancer, in the blood.
TEST-1790
CD103 Immunohistochemistry (IHC) Test

This diagnostic test evaluates the presence and expression level of the CD103 protein on tumour cells within a tissue sample.

Archival Tissue Specimen (FFPE Block or Biopsy Slides) 5-7 Working Days 450.00 AED
View
View test specifications and preparation
What it measures
["CD103 integrin ฮฑEฮฒ7 expression", "Tumour cell protein expression"]
Parameters
[]
Preparation
[]
Indications
["Suspected hairy cell leukaemia", "Suspected specific subtypes of T-cell lymphoma", "Classification of haematological malignancies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 104535-2 ICD-10: C91.4
Clinical summary
This diagnostic test evaluates the presence and expression level of the CD103 protein on tumour cells within a tissue sample.
TEST-1971
CD19 Immunohistochemistry Test

This diagnostic test evaluates the presence or absence of the CD19 protein marker in tissue samples.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Unstained Slides 5-7 business days 550.00 AED
View
View test specifications and preparation
What it measures
["CD19 B-cell antigen presence"]
Parameters
[]
Preparation
["No special patient preparation needed", "Provide original pathology report and block identification details"]
Indications
["Diagnosis of B-cell lymphomas", "Classification of lymphoid neoplasms", "Guiding targeted immunotherapy decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 40582-8 ICD-10: C85.90
Clinical summary
This diagnostic test evaluates the presence or absence of the CD19 protein marker in tissue samples.
TEST-1982
CD45RO (Pan T Cell Marker) Immunohistochemistry Test

This diagnostic test evaluates tissue samples for the presence of the CD45RO antigen, a marker associated with memory T-cells and certain lymphomas.

FFPE Tissue Block or Biopsy Slides (Archival Tissue Specimen) 5 Days (Routine FFPE Block) / 7 Days (Large Tissue) 450.00 AED
View
View test specifications and preparation
What it measures
["CD45RO antigen expression", "Memory T-cell infiltration"]
Parameters
[]
Preparation
["No fasting required", "Ensure formalin-fixed tissue block or fresh biopsy is accompanied by histopathology report, biopsy site, and clinical history"]
Indications
["Diagnosis of T-cell lymphomas", "Classification of lymphoid malignancies", "Immune monitoring"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33949-0 ICD-10: C84.40
Clinical summary
This diagnostic test evaluates tissue samples for the presence of the CD45RO antigen, a marker associated with memory T-cells and certain lymphomas.

Category overview

Histology: overview

Gaining clarity at the microscopic level is a critical step in accurately identifying the root causes of underlying health concerns. At DNA Labs UAE, our Histology services provide meticulous tissue examinations using advanced staining techniques and high-resolution microscopy. This in-depth histological testing in the UAE equips your healthcare provider with the precise structural details necessary to guide their clinical decision-making and patient care. As one of the most respected diagnostic labs in Dubai/UAE, we are dedicated to providing fast, pinpoint-accurate turnaround times while safeguarding your sensitive health information with strict confidentiality. Move forward with confidence. Explore our histology diagnostic services, coordinate a sample collection with your physician, or contact our specialists for more information.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area